Renal disease progression in autosomal dominant polycystic kidney disease

Clinical and Experimental Nephrology

Volumn 16, Issue 4, 2012, Pages 622-628

  Higashihara, Eiji ^a   Horie, Shigeo ^b   Muto, Satoru ^b   Mochizuki, Toshio ^c   Nishio, Saori ^c   Nutahara, Kikuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autosomal dominant polycystic kidney disease; Glomerular filtration rate; Kidney failure; Kidney function; Kidney volume

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY;

ADULT; AGING; BLOOD PRESSURE; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; RETROSPECTIVE STUDIES;

EID: 84865129843     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0611-9     Document Type: Article

References (21)

1. KA Franz FC Reubi 1983 Rate of functional deterioration in polycystic kidney disease Kidney Int 23 526 529 6405076 10.1038/ki.1983.51 1:STN:280:DyaL3s7ptVWqsA%3D%3D (Pubitemid 13117121)
2. JJ Grantham AB Chapman VE Torres 2006 Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes Clin J Am Soc Nephrol 1 148 157 17699202 10.2215/CJN.00330705
3. JJ Grantham VE Torres AB Chapman LM Guay-Woodford KT Bae BF King Jr LH Wetzel, et al. 2006 Volume progression in polycystic kidney disease N Engl J Med 354 2122 2130 16707749 10.1056/NEJMoa054341 1:CAS:528:DC%2BD28XkslCrsr0%3D (Pubitemid 43736612)
4. EM Meijer M Rook H Tent G Navis EJ van der Jagt PE de Jong, et al. 2010 Early renal abnormalities in autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 5 1091 1098 20413443 10.2215/CJN.00360110 1:CAS:528: DC%2BC3cXptV2mtLY%3D
5. I Helal B Reed K McFann X Yan GM Fick-Brosnahan M Cadnapaphornchai, et al. 2011 Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 6 2439 2443 21903987 10.2215/CJN.01010211
6. P Ruggenenti A Remuzzi P Ondei G Fasolini L Antiga B Ene-Iordachf, et al. 2005 Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease Kidney Int 68 206 216 15954910 10.1111/j.1523-1755.2005.00395.x 1:CAS:528:DC%2BD2MXmt1Cgtrk%3D (Pubitemid 43181378)
7. MC Hogan TV Masyuk LJ Page VJ Kubly EJ Bergstralh X Li, et al. 2010 Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease J Am Soc Nephrol 21 1052 1061 20431041 10.1681/ASN.2009121291 1:CAS:528:DC%2BC3cXot1Gru7Y%3D
8. N Perico L Antiga A Caroli P Ruggenenti G Fasolini M Cafaro, et al. 2010 Sirolimus therapy to halt progression of ADPKD J Am Soc Nephrol 21 1031 1040 20466742 10.1681/ASN.2009121302 1:CAS:528:DC%2BC3cXot1Gru7g%3D
9. AL Serra D Poster AD Kistler F Krauer S Raina J Young, et al. 2010 Sirolimus and kidney growth in autosomal dominant polycystic kidney disease N Engl J Med 363 879 881 10.1056/NEJMoa0907419
10. G Walz K Budde M Mannaa J Nurnberger C Wanner C Sommerer, et al. 2010 Everolimus in patients with autosomal dominant polycystic kidney disease N Engl J Med 363 830 840 20581392 10.1056/NEJMoa1003491 1:CAS:528:DC%2BC3cXhtVyksb3I
11. E Higashihara VE Torres AB Chapman JJ Grantham K Bae TJ Watnick, et al. 2011 Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience Clin J Am Soc Nephrol 6 2499 2507 21903984 10.2215/CJN.03530411 1:CAS:528:DC%2BC3MXhs1WgtrnJ
12. S Matsuo E Imai M Horio Y Yasuda K Tomita K Nitta, et al. 2009 Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 982 992 19339088 10.1053/j.ajkd.2008.12.034 1:CAS:528:DC%2BD1MXnslKku7c%3D
13. Work group and evidence review team membership 2002 K/DOQI clinical practice guidelines on chronic kidney disease Am J Kidney Dis 39 S1 S216 10.1016/S0272-6386(02)70081-4
14. KT Bae PK Commean J Lee 2000 Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease J Comput Assist Tomogr 24 614 619 10966197 10.1097/00004728-200007000-00019 1:STN:280:DC%2BD3cvivVKntw%3D%3D (Pubitemid 32204335)
15. AB Chapman LM Guay-Woodford JJ Grantham VE Torres KT Bae DA Baumgarten, et al. 2003 Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort Kidney Int 64 1035 1045 12911554 10.1046/j.1523-1755.2003.00185.x (Pubitemid 37013840)
16. E Higashihara K Nutahara M Kojima A Tamakoshi Y Ohno H Sakai, et al. 1998 Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan Nephron 80 421 427 9832641 10.1159/000045214 1:STN:280:DyaK1M%2FlsVyjug%3D%3D (Pubitemid 28554689)
17. VE Torres X Wang Q Qian S Somlo PC Harris VH Gattone 2004 Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease Nat Med 10 363 364 14991049 10.1038/nm1004 1:CAS:528: DC%2BD2cXis1ekt7o%3D (Pubitemid 38508512)
18. E Meijer RT Gansevoort PE de Jong AM van der Wal WN Leonhard SR de Krey, et al. 2011 Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug Nephrol Dial Transplant 26 2445 2453 21393612 10.1093/ndt/gfr069 1:CAS:528:DC%2BC3MXps1yku74%3D
19. AM Johnson PA Cabow 1997 Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease J Am Soc Nephrol 8 1560 1567 9335384 1:STN:280:DyaK2svnsVelsg%3D%3D (Pubitemid 27496474)
20. MA Cadnapapahornchai K McFann JD Strain A Masoumi RW Schrier 2009 Prospective change in renal volume and function in children with ADPKD Clin J Am Soc Nephrol 4 820 829 10.2215/CJN.02810608
21. B Orskov ML Borresen B Feldt-Rasmussen O Ostergaard I Laursen S Strandgaard 2010 Estimating glomerular filtration rate using the new CKD-EPI equation and other equations in patients with autosomal dominant polycystic kidney disease Am J Nephrol 31 53 57 19887788 10.1159/000256657